NEUTRISCI INTERNATIONAL INC (NU.CA) Stock Price & Overview

TSX-V:NUCA64129Y1079

Current stock price

0.005 CAD
0 (0%)
Last:

The current stock price of NU.CA is 0.005 CAD. Today NU.CA is down by 0%. In the past year, price decreased by -66.67%.

NU.CA Key Statistics

52-Week Range0.005 - 0.02
Current NU.CA stock price positioned within its 52-week range.
1-Month Range0.005 - 0.01
Current NU.CA stock price positioned within its 1-month range.
Market Cap
892.121K
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
N/A
Dividend Yield
N/A

NU.CA Stock Performance

Today
0%
1 Week
N/A
1 Month
N/A
3 Months
N/A
Longer-term
6 Months N/A
1 Year -66.67%
2 Years -80.00%
3 Years -97.14%
5 Years -93.75%
10 Years N/A

NU.CA Stock Chart

NEUTRISCI INTERNATIONAL INC / NU Daily stock chart

NU.CA Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to NU.CA. When comparing the yearly performance of all stocks, NU.CA is a bad performer in the overall market: 90.49% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

NU.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to NU.CA. NU.CA has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NU.CA Earnings

Next Earnings DateN/A
Last Earnings DateN/A
PeriodQ3 / 2023
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

NU.CA Forecast & Estimates


Analysts
Analysts0
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

NU.CA Groups

Sector & Classification

Index Membership

NU.CA Financial Highlights


Income Statements
Revenue(TTM)59.98K
Net Income(TTM)-552.46K
Industry RankSector Rank
PM (TTM) N/A
ROA -432.18%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%12.7%
Sales Q2Q%-46.99%
EPS 1Y (TTM)42.21%
Revenue 1Y (TTM)-86.13%

NU.CA Ownership

Ownership
Inst Owners1.29%
Shares178.42M
Float175.13M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

About NU.CA

Company Profile

NU logo image NeutriSci International, Inc. engages in the development, formulation, and production of products for the Nutraceutical and CBD/THC industries. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2001-07-09. The firm is focused on the market development for its nutraceutical products. Its products utilize patented form of Pterostilbene called pTeroPure. pTeroPure Pterostilbene is a form of all-trans Pterostilbene that is found naturally in blueberries and is manufactured for NeutriSci by ChromaDex Corp. (ChromaDex) in the United States. NeutriSci’s neuenergy product is an energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash that is associated with energy products. The company has developed proprietary IP and technology (NeutriSci IP) that creates an efficient method of bilingual absorption of nutraceuticals into the bloodstream. NeutriSci’s IP can be applied to many different categories in the beverage, food, and nutraceutical space.

Company Info

IPO: 2001-07-09

NEUTRISCI INTERNATIONAL INC

1600 - 609 Granville St

Vancouver BRITISH COLUMBIA V7Y 1C3 CA

CEO: Scott Ackerman

Employees: 0

NU Company Website

Phone: 17783318505

NEUTRISCI INTERNATIONAL INC / NU.CA FAQ

What does NU do?

NeutriSci International, Inc. engages in the development, formulation, and production of products for the Nutraceutical and CBD/THC industries. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2001-07-09. The firm is focused on the market development for its nutraceutical products. Its products utilize patented form of Pterostilbene called pTeroPure. pTeroPure Pterostilbene is a form of all-trans Pterostilbene that is found naturally in blueberries and is manufactured for NeutriSci by ChromaDex Corp. (ChromaDex) in the United States. NeutriSci’s neuenergy product is an energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash that is associated with energy products. The company has developed proprietary IP and technology (NeutriSci IP) that creates an efficient method of bilingual absorption of nutraceuticals into the bloodstream. NeutriSci’s IP can be applied to many different categories in the beverage, food, and nutraceutical space.


Can you provide the latest stock price for NEUTRISCI INTERNATIONAL INC?

The current stock price of NU.CA is 0.005 CAD.


What is the dividend status of NEUTRISCI INTERNATIONAL INC?

NU.CA does not pay a dividend.


How is the ChartMill rating for NEUTRISCI INTERNATIONAL INC?

NU.CA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Can you provide the ownership details for NU stock?

You can find the ownership structure of NEUTRISCI INTERNATIONAL INC (NU.CA) on the Ownership tab.